Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT07242404
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18 years or older.
* Diagnosed with one of the following:
* Chronic hepatitis B or compensated HBV-related cirrhosis (based on the 2022 Chinese CHB guidelines), or
* Metabolic dysfunction-associated fatty liver disease (MAFLD), metabolic dysfunction-associated steatohepatitis (MASH), or fibrosis/cirrhosis due to MAFLD (based on the 2024 MAFLD guidelines).
* Willing and able to provide written informed consent.
Exclusion Criteria:
* Chronic liver disease due to other etiologies (e.g., other viral hepatitis, autoimmune liver disease, alcoholic liver disease, genetic/metabolic liver disease).
* Evidence of decompensated cirrhosis.
* Total bilirubin \> 51 μmol/L.
* ALT \> 5 × upper normal limit.
* Presence of hepatocellular carcinoma, hepatic hemangioma, large hepatic cyst, or other space-occupying liver lesions.
* Co-infection with HIV.
* History of liver transplantation or TIPS.
* Pregnancy.
* Congestive hepatopathy.
* Unhealed wounds in the right upper abdomen.
* Inability to maintain the required sitting position.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07242404
Study Brief:
Protocol Section:
NCT07242404